What You Should Know: - Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. - MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. - With this acquisition, Medidata’s integrated offering will help provide life sciences companies and device
Read More
Digital Biomarkers
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know: - physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. - Early detection of COVID-19 decompensation in patients is complicated by infrequent and non-specific clinical data. The first-in-kind tool will collect and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. The National Cancer Institute
Read More
Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch
What You Should Know: - Anthem, Inc. announced a new study that examines how the use of everyday devices, like Apple Watch and iPhone, may help individuals with asthma, led by the University of California, Irvine. - Launching in the fall, the two-year, randomized controlled study will enroll participants from Anthem-affiliated health plans who have been clinically diagnosed with asthma. -Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple Watch
Read More
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
What You Should Know: - Sonde Health acquires NeuroLex Laboratories, Inc. to forms one of the world’s preeminent biobanks focused on vocal biomarkers. - NeuroLex’s core product, SurveyLex, makes it easy to create and distribute voice surveys in less than a minute as URL links through web browsers. Sonde Health, a Boston-based digital vocal biomarker technology platform announced it has acquired NeuroLex Laboratories, Inc., a leading voice-enabled survey and data acquisition platform.
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know: - AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera. - AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment. AiCure,
Read More
Backed by Optum Ventures, Kaia Health Raises $8M for AI-Driven Digital Therapeutics for Back Pain & COPD
- Digital therapeutics startup Kaia Health raises $8M in funding led by Optum Ventures to support the accelerated execution of clinical trials required to demonstrate efficacy to the FDA.- Kaia Health utilizes multimodal therapy, which combines physical, psychological and educational elements to relieve back pain at home, without medication.- Optum’s investment in Kaia Health will consider use of Kaia Health’s digital therapeutic offerings for back pain and COPD with Optum and UnitedHealth
Read More
Altoida Raises $6.3M for Early Detection of Alzheimer’s Using AI & Augmented Reality
Altoida Inc., a digital health company using digital biomarkers to drive better clinical outcomes for brain diseases has raised $6.3M in Series A funding led by M Ventures, the corporate venture capital arm of the science and technology company Merck KGaA, Darmstadt, Germany. The round also includes participation from Grey Sky Venture Partners, VI Partners AG, Alpana Ventures, and FYRFLY Venture Partners. Taking Aim at the Alzheimer’s Disease Epidemic The number of people living with
Read More
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More
Mindstrong Health, Takeda Partner to Develop Digital Biomarkers for Mental Health Conditions
Mindstrong Health, a digital health startup transforming the diagnosis and treatment of neuropsychiatric disorders, has entered into a partnership with Takeda Pharmaceutical Company Limited to explore the development of digital biomarkers for selected mental health conditions, in particular schizophrenia and treatment-resistant depression.In this decade, neuropsychiatric disorders represent the largest source of medical disability for people under age 50. The costs are among the highest of all
Read More
